MedTrace Logo

Three Anxiolytic Drugs Used in Third Molar Surgery

NCT02065843 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-10-28

No results posted yet for this study

Summary

This study was to compare the effectiveness of three drugs (Passiflora incarnata, Erythrina mulungum, Midazolam) in controlling anxiety in patients undergoing bilateral extraction of asymptomatic, impacted mandibular third molars.

Conditions

  • Dental Anxiety
  • Impacted Third Molar Tooth

Interventions

DRUG

Mulungu

500 mg/single dose/1 hour before dental surgery

DRUG

Placebo

500 mg/single dose/1 hour before dental surgery

DRUG

Passiflora incarnata

100 mg/single dose/1 hour before dental surgery

DRUG

midazolam

15 mg/single dose/1 hour before dental surgery

Sponsors & Collaborators

  • University of Campinas, Brazil

    collaborator OTHER

  • Universidade Federal de Sergipe

    lead OTHER

Principal Investigators

  • Liane M Souza, PhD · Federal University of Sergipe

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-04-30
Completion
2014-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02065843 on ClinicalTrials.gov